|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2001-6-18
|
|
pubmed:abstractText |
This multicenter, double-blind, randomised study was undertaken to determine the efficacy and safety of a combination of troxerutin 150 mg and carbazochrome 1.5 mg compared to carbazochrome alone in patients with acute uncomplicated hemorrhoids. Patients were administered by the intramuscular route (one ampoule) twice daily for one week. Both subjective and objective efficacy variables significantly improved in the combination drug group only, thus demonstrating the rationale for a combination therapy. Treatments were safe and well tolerated either at a local or systemic level.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1128-3602
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11409185-Adrenochrome,
pubmed-meshheading:11409185-Adult,
pubmed-meshheading:11409185-Double-Blind Method,
pubmed-meshheading:11409185-Drug Combinations,
pubmed-meshheading:11409185-Female,
pubmed-meshheading:11409185-Hemorrhoids,
pubmed-meshheading:11409185-Hemostatics,
pubmed-meshheading:11409185-Humans,
pubmed-meshheading:11409185-Hydroxyethylrutoside,
pubmed-meshheading:11409185-Male,
pubmed-meshheading:11409185-Vasoconstrictor Agents
|
|
pubmed:articleTitle |
Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids.
|
|
pubmed:affiliation |
Istituto di Farmacologia, Servizio di Farmacologia Clinica, Università degli Studi di Messina, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
